The University of Kansas Cancer Center
Scott Weir has extensive experience in the field of medical innovation and translational research, currently serving as the Director of The Institute for Advancing Medical Innovation at The University of Kansas Cancer Center since February 2006. The institute focuses on transforming laboratory discoveries into therapies for cancer, neurologic, and rare diseases, with backing from the Ewing Marion Kauffman Foundation. Additionally, Scott Weir holds the position of Associate Director for Translational Research at the same institution. Prior to this, Scott Weir was the Vice President of Early Development and Laboratory Services at Quintiles Inc. and Director, Acting Vice President at Hoescht Marion Roussel. Scott Weir earned a PharmD and PhD in Pharmacokinetics and Biopharmaceutics from the University of Nebraska Medical Center between 1983 and 1986.
This person is not in the org chart
The University of Kansas Cancer Center
1 followers
The University of Kansas Cancer Center is the region's only National Cancer Institute-designated comprehensive cancer center, and one of only 53 nationally. Our extraordinary, multidisciplinary team members work together to transform cancer research and clinical care, with the unified goal of achieving a cancer-free world. Our partnerships include cancer research and healthcare professionals associated with the University of Kansas Medical Center and The University of Kansas Health System in Kansas City, the University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, Stowers Institute for Medical Research, Children’s Mercy and members of Masonic Cancer Alliance. For more information on The University of Kansas Cancer Center's research and outreach programs and award-winning patient care, visit www.kucancercenter.org/. Follow us on social media: - Twitter:@KUCancerCenter - Instagram: @KUCancerCenter - Facebook:www.facebook.com/kucancercenter